Загрузка...
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease in the Western world and is closely associated with metabolic syndrome, which includes hypertension, central obesity, dyslipidemia and insulin resistance. NAFLD includes a wide spectrum of liver alterations, ranging from...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Co., Limited
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4009475/ https://ncbi.nlm.nih.gov/pubmed/24799988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i4.199 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|